Picture of Codexis logo

CDXS Codexis Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Codexis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-21.3-33.6-76.2-65.3-44
Depreciation
Non-Cash Items11.417.936.322.912.9
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-7.6221.6-18.2-126.42
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-14.311.3-52.6-49.4-19.4
Capital Expenditures-13.8-8.31-4.42-4.3-4.47
Purchase of Fixed Assets
Other Investing Cash Flow Items-7.59-5.27-0.44-52.728
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-21.4-13.6-4.86-5723.5
Financing Cash Flow Items-1.41-1.53-0.907-2.35-0.839
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3.77-0.5758.1760.527.9
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-31.9-2.87-49.3-45.932.1